SWStonkWhisper
← Back to Intel
Insider ActivityLBRX

Deep Track Biotechnology Master Fund, Ltd., Insider at LB PHARMACEUTICALS INC, bought $10.0M of LBRX

Last updated Aug 12, 2026

This page documents an SEC Form 4 insider trading disclosure for $LBRX securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.

Deep Track Biotechnology Master Fund, Ltd. Insider
LB PHARMACEUTICALS INC · $LBRX
$10.0M Total Value
286,205 Shares Traded
$34.9399 Price / Share
Shares Owned After
2026-08-03 Filing Date

Transaction Details

InsiderDeep Track Biotechnology Master Fund, Ltd.
TitleInsider
CompanyLB PHARMACEUTICALS INC
TickerLBRX
Transaction TypePurchase
Transaction Date2026-07-30
Shares Traded286,205
Price Per Share$34.9399
Total Value$10.0M
Filed Date2026-08-03
Accession Number0001193125-26-331058

Ownership Context

Shares Owned After Transaction
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-331058

Other Insider Trades — LBRX

Other Trades by Deep Track Biotechnology Master Fund, Ltd.

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LBRX — LB PHARMACEUTICALS INC →

Whisper Score — LBRX

19.38
Dead Silence
Current Whisper Score

See full analysis for LBRX →

Track LBRX insider activity in real time on The Wire →

Get alerts when Deep Track Biotechnology Master Fund, Ltd. files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: August 12, 2026 at 07:04 UTC

Not Financial Advice: This article is for informational and educational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. StonkWhisper aggregates publicly available data from verified regulatory filings and proprietary analysis pipelines. All investment decisions are made solely at your own risk. Guerilla Finance LLC is not a registered investment advisor or broker-dealer. Always consult a qualified financial professional before making investment decisions.

Want real-time data? Access The Wire for live sentiment tracking.